Fondazione Edmund Mach
Fondazione Edmund Mach
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Myrosinase Bioactivated Gglucoraphanin for the Treatment of Neurodegenerative Diseases (GRA-MYR-ND) | CNS demyelinating autoimmune disease, Parkinson disease, autoimmune disease, autoimmune disorder of the nervous system, basal ganglia disorder, brain disorder, central nervous system disorder, demyelinating disease, immune system disorder, movement disorder, multiple sclerosis, nervous system disorder, neurodegenerative disease, parkinsonian disorder, relapsing-remitting multiple sclerosis, synucleinopathy | Recruiting | Not applicable | 2026-01-22 | NCT07360977 |